0000896262-21-000030.txt : 20210219 0000896262-21-000030.hdr.sgml : 20210219 20210219161414 ACCESSION NUMBER: 0000896262-21-000030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210217 FILED AS OF DATE: 20210219 DATE AS OF CHANGE: 20210219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gerard Christopher CENTRAL INDEX KEY: 0001694097 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 21655729 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY, SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 4 1 wf-form4_161376923205235.xml FORM 4 X0306 4 2021-02-17 0 0000896262 AMEDISYS INC AMED 0001694097 Gerard Christopher 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 0 1 0 0 Chief Operating Officer Common Stock 2021-02-17 4 M 0 8090 0 A 30218 D Common Stock 2021-02-17 4 M 0 6036 0 A 36254 D Common Stock 2021-02-17 4 F 0 3184 295.20 D 33070 D Common Stock 2021-02-17 4 F 0 595 295.20 D 32475 D Common Stock 2021-02-17 4 A 0 1525 0 A 34000 D Common Stock 2021-02-17 4 A 0 10163 0 A 44163 D Common Stock 279 I Through 401(k) Plan Restricted Stock Units 2021-02-17 4 M 0 8090 0 D Common Stock 8090.0 0 D Restricted Stock Unit (Performance-Based Vesting) 2021-02-17 4 M 0 3018 0 D Common Stock 3018.0 0 D Stock Option (Right to Buy) 295.2 2021-02-17 4 A 0 3840 0 A 2031-02-17 Common Stock 3840.0 3840 D Restricted Share Units (Performance-Based Vesting) 2021-02-17 4 A 0 3049 0 A Common Stock 3049.0 3049 D On February 12, 2020, the Reporting Person was awarded performance-based Restricted Stock Units ("RSUs") with vesting provisions based on certification of achievement of an identified performance measure for 2020, with additional time-based vesting in equal 25% installments on each of the certification date and February 20, 2022, 2023 and 2024, assuming the Reporting Person remains continuously employed on the vesting date. The amount reported in a Form 4 filed on February 14, 2020 was 3,018 RSUs, which was the amount of shares payable at target performance; the Reporting Person was eligible to earn 50%-200% of the amount reported depending on the level of performance achieved. On February 17, 2021, the Compensation Committee of the Issuer's Board of Directors certified achievement of the 2020 performance measure at 200%, thereby resulting in the Reporting Person earning 6,036 RSUs, which are reported in Table I. The Issuer awarded the Reporting Person 1,525 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 25% installments on each of February 20, 2022, 2023, 2024 and 2025, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs. The Issuer awarded the Reporting Person 10,163 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 50% installments on each of February 20, 2024 and February 20, 2025, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs. The information in this report is based on a plan statement dated as of December 31, 2020. The RSUs are subject to performance-based vesting and will vest (i) on the certification by the Compensation Committee of the Issuer's Board of Directors of the achievement of identified performance goals for fiscal years 2017 through 2020, respectively, and (ii) additional time-based vesting conditions (2017 Tranche: one-third on each of January 20, 2018, 2019 and 2020; 2018 Tranche: one-third on each of January 20, 2019, 2020 and 2021; 2019 Tranche: one-third on January 20, 2020, and two-thirds on January 20, 2021; 2020 Tranche: all on January 20, 2021), assuming the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs. The performance criteria for fiscal year 2020 were met. The Stock Options are subject to time-based vesting conditions and will vest in equal, 25% installments on each of February 20, 2022, 2023, 2024 and 2025, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options. The performance-based RSUs will vest based on certification of achievement of an identified performance measure for 2021, with additional time-based vesting in equal 25% installments on each of the certification date and February 20, 2023, 2024 and 2025, assuming the Reporting Person remains continuously employed on the vesting date. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 50%-200% of the amount reported depending on the level of performance achieved. /s/ Jennifer R. Guckert, pursuant to a power of attorney 2021-02-19